ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET

About this update from Ani Pharmaceuticals, Inc.

[{"type":"image","alt":"ANI Pharmaceuticals, Inc.","displaySize":"","headline":null,"caption":"ANI Pharmaceuticals, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":270,"height":114,"url":"https://media.zenfs.com/en/globenewswire.com/affa8ae63629bff3d190d327bdae162e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ropAbm4enKilJXBFvyz.RQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3NztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/affa8ae63629bff3d190d327bdae162e","width":270,"height":114}},"lazy":false},{"type":"text","content":"PRINCETON, N.J., Feb. 13, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its fourth quarter and full year 2025 financial results on Friday, February 27, 2026, prior to the market open.","length":270,"tagName":"p"},{"type":"text","content":"Nikhil Lalwani, President and Chief Executive Officer, Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, and Chris Mutz, Head of Rare Disease will host a conference call to discuss the results as follows:","length":233,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"vertical-align:bottom;","val":[{"type":"text","content":"Date","length":4,"tagName":"p","attribs":{}}]},{"style":"vertical-align:bottom;","val":[{"type":"text","content":"Friday, February 27, 2026","length":25,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:bottom;","val":[{"type":"text","content":"Time","length":4,"tagName":"p","attribs":{}}]},{"style":"vertical-align:bottom;","val":[{"type":"text","content":"8:00 a.m. ET","length":12,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:bottom;","val":[{"type":"text","content":"Toll free (U.S.)","length":16,"tagName":"p","attribs":{}}]},{"style":"vertical-align:bottom;","val":[{"type":"text","content":"800-274-8461","length":12,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:bottom;","val":[{"type":"text","content":"Conference ID","length":13,"tagName":"p","attribs":{}}]},{"style":"vertical-align:bottom;","val":[{"type":"text","content":"5230834","length":7,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:bottom;","val":[{"type":"text","content":"Webcast (live and replay)","length":25,"tagName":"p","attribs":{}}]},{"style":"vertical-align:bottom;","...

More updates from Ani Pharmaceuticals, Inc.